Tuesday, May 19, 2020

Tumor Ablation Market Forecasts to 2030 Regional Development, Trends, Strategy and Profitability Analysis - Medtronic, Integra LifeSciences

Tumor ablation market was estimated to be over US$ 545.3 Million in 2018. It is anticipated to grow at a CAGR of 11.1% from 2019 to 2030.

The growth of market can be attributed to several factors, such as growing geriatric population and increasing cancer population, which has led to its wide-scale adoption. As per, Population Projections 2017-2060 by US Census Bureau, the number of adults, aged 85yrs and above are expected to nearly triple from 6.4 million in 2016 to 19.0 million by 2060. According to a recent study by American Cancer Society, cancer usually develops in older people and 80% of all cancers in the United States are diagnosed in people of 55 years or older. The rapidly growing older population will increase demand for cancer care, which will in turn have a substantial impact on growth of tumor ablation market.

Major Key Players of the Tumor Ablation Market are:Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others.

Read More @ https://www.openpr.com/news/2020098/tumor-ablation-market-forecasts-to-2030-regional-development 


No comments:

Post a Comment